You are not currently logged in.

Access JSTOR through your library or other institution:


Log in through your institution.

Journal Article

Mycobacterium bovis Osteomyelitis Involving a Hip Arthroplasty after Intravesicular Bacille Calmette-Guérin for Bladder Cancer

Carmen E. Guerra, Robert F. Betts, Regis J. O'Keefe and Jack W. Shilling
Clinical Infectious Diseases
Vol. 27, No. 3 (Sep., 1998), pp. 639-640
Published by: Oxford University Press
Stable URL:
Page Count: 2
  • Download ($42.00)
  • Subscribe ($19.50)
  • Add to My Lists
  • Cite this Item
Preview not available
Preview not available


Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is one of the most effective agents in the treatment of superficial bladder cancer. BCG osteomyelitis is an infrequent complication of intravesicular BCG therapy; only five cases of BCG vertebral osteomyelitis have been reported in the literature. Similarly, the infection of an indwelling extravascular device by BCG is rare; there is only one previous report documenting infection associated with an automated implantable cardiac defibrillator. We report a case of BCG osteomyelitis involving a hip arthroplasty that occurred after intravesicular administration of BCG for bladder cancer, and we review the risk factors predisposing to such infections and their treatment.

Page Thumbnails

  • Thumbnail: Page 
  • Thumbnail: Page